跳至主要内容
临床试验/NCT04715321
NCT04715321Unknown不适用

Computed Tomography Perfusion Parameters Predict Vascular Pattern in Hepatocellular Carcinoma: A Prospective Study

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2013年2月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
Predictive performance of CT perfusion

研究概览

简要总结

Distinct vascular patterns (ECTC or Non-ECTC) of tumors plays an important role in tumor migration, metastasis and drug resistant in hepatocellular carcinoma (HCC). However, there is no non-invasive method to predict vascular pattern in clinical. In the present study, we prospectively assess CT perfusion parameters for evaluation of the vascular pattern in HCC.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age over than 18 years old
  • tumor size of less than 5 cm
  • Child-Pugh A class liver function
  • an Eastern Cooperative Oncology Group performance status of 0
  • no previous treatment for HCC
  • pathological diagnosis of hepatocellular carcinoma
  • adequate organ function (white blood cell count ≥3.0 × 109/L, absolute neutrophil count ≥1.5 × 109/L, platelet count ≥75 × 109/L, aspartate transaminase and alanine transaminase≤5 × upper limit of the normal, creatinine clearance rate of ≤1.5 × upper limit of the normal, and left ventricular ejection ≥45%)

排除标准

  • Patients who received antitumor therapy before recurrence, including radiotherapy, transarterial chemoembolization, tyrosine kinase inhibitor, and immune checkpoint inhibitor
  • a known medical history of HIV infection
  • pregnancy or breastfeeding
  • portal vein tumor thrombosis or hepatic vein thrombosis detected by any routine imaging modality, including ultrasonography, dynamic contrast CT and MRI
  • any evidence of tumor metastasis or prior recurrence
  • hepatic decompensation

结局指标

主要结局

Predictive performance of CT perfusion

时间窗: 6 months

The primary outcome of our study is to evaluate the sensitivity and specifity of CT perfusion in predicting vascular pattern of HCC

次要结局

  • Disease-free survival (DFS)(6 months)
  • Overall survival (OS)(6 months)

研究者

发起方
Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shi Ming

Professor

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验